West Pharmaceutical Services, Inc.

WSTNYSE • USD
364.98 USD
↘ 0.03 (0.01%)AT CLOSE (03:59 PM EDT)
375.45
↗ 10.47 (2.87%)
POST MARKET (AS OF 08:10 PM EDT)
Post Market
AS OF 08:10 PM EDT
375.45
↗ 10.47 (2.87%)
🔴Market: CLOSED

West Pharmaceutical Services, Inc. (WST) is currently trading at $364.98. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Buy" and "Strong Buy" respectively. Key drivers include a robust Altman Z-Score, a strong Piotroski F-Score of 7/9, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, WST is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Oct 2, 2026.

Open?$364.74
High?$368.85
Low?$363.26
Prev. Close?$365.01
Volume?473.0K
Avg. Volume?570.7K
VWAP?$366.31
Rel. Volume?0.83x
Bid / Ask
Bid?$364.69 × 200
Ask?$408.70 × 100
Spread?$44.01
Midpoint?$386.70
Valuation & Ratios
Market Cap?25.7B
Shares Out?70.4M
Float?70.0M
Float %?99.4%
P/E Ratio?45.47
P/B Ratio?8.59
EPS?$8.03
Dividend?0.23%
Ex-Dividend?N/A
RelatedEHCCHE
News
Profile
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Employees
10.8K
Market Cap
25.7B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
1973-01-02
Address
530 HERMAN O. WEST DRIVE
EXTON, PA 19341
Phone: (610) 594-2900
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookStrong Buy
Strong SellNeutralStrong Buy
F-Score?
88
Z-Score?
100
Momentum?
92
Short Sent.?
64
Piotroski F-Score?7/9Strong
Altman Z-Score?17.52Safe
Confidence?75%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?3.40%Low
Short Interest?2.4M
Days to Cover?4.5
Free Float70.0M
Avg Daily Volume526.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.82Strong
Quick Ratio?2.12Strong
Cash Ratio?0.68Adequate
Debt/Equity?0.07Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
33/100
P/E?
Peers
33
S&P
15
45.5PRICEY▾
P/B?
Peers
33
S&P
22
8.59HIGH▾
P/S?
Peers
33
S&P
14
7.72HIGH▾
P/FCF?
Peers
33
S&P
8
58.8PRICEY▾
EV/EBITDA?
Peers
33
S&P
12
28.2HIGH▾
EV/Sales?
Peers
33
S&P
18
7.65HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
64
18.9%STRONG▾
ROA?
Peers
67
S&P
84
13.9%STRONG▾
Cash Flow & Enterprise
FCF?$436.9M
Enterprise Value?$25.5B
Fundamentals ratios updated end of day